Cognizant Technology Solutions (CTSH) will provide end-to-end support for the development and implementation of an artificial intelligence platform for research and development at Tokyo Research Park and Fuji Research Park, the company said late Sunday.

The platform, named Benchling, will be operated by pharmaceutical company Kyowa Kirin. It will allow scientists to capture structured data, run AI models and agents, and automate workflows, Cognizant said.

Cognizant said that, in collaboration with Benchling, it will provide support across the process, including platform setup, data migration, system implementation and ongoing maintenance following deployment.